Should a Psychiatrist Prescribe a Nanodrug to Help Parents Monitor a Teen's Adherence?
This case explores ethical questions about tracking medication adherence in a 16-year-old patient with schizophrenia. Relevant stakeholders are the teen, the parents, and society. How those stakeholders' interests should be considered is explored here in the context of the psychiatrist's professional care management responsibilities and the burdens each stakeholder must bear over the course of the patient's care.